Vicki Anastasi leads ICON’s Medical Device and Diagnostics Research, RWE & Late Phase research groups at ICON. She guides pharmaceutical, biotechnology and medical device companies in developing and implementing roadmaps for demonstrating drug and device value, safety and effectiveness by leading innovative approaches including RWE initiatives, Ph IIIb/IV, pilot/pivotal studies and HEOR evaluations across the globe to optimize market access.
Vicki has over twenty five years of experience in the clinical research industry, with over fifteen years specifically focused on global medical strategic consulting.
Prior to joining the company in 2007, she held senior management roles for medical device and therapeutic companies focused in orthopedics, cardiovascular/metabolic disease and combination products. In diagnostics, she held senior positions at companies involved in the development of infectious disease and genetic-based products including companion diagnostics and precision medicine.
Vicki is actively involved in industry groups, where she regularly speaks and participates in focused panels and discussions.